ErtasFAvciEKirisT. The ratio of fibrinogen to albumin as a predictor of contrast-induced nephropathy after carotid angiography[published online October 29, 2018]. Angiology. doi:10.1177/0003319718809200.
2.
UzunhasanIYildizAArslanS, et al.Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome. Angiology. 2017;68(7):621–6.
3.
SunGChenPWangK. Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction[published online October 15, 2018]. Angiology. 2018. doi:10.1177/0003319718803677.
4.
HossainMACostanzoECosentinoJ, et al.Contrast-induced nephropathy: pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transpl. 2018;29(1):1–9.
5.
OweisAOAlshellehSADaoudAK, et al.Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study. Int J Nephrol Renovasc Dis. 2018;11:211–5.
6.
NijssenECRennenbergRJNelemansPJ, et al.Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–22.
7.
ChenYLFuNKXuJ, et al.A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2014;83(1):E8–E16.
8.
AkbogaMKYalcinRSahinarslanA, et al.Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323–7.
9.
YilmazSAkbogaMKSenF, et al.Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–66.
10.
AkbogaMKCanpolatUSahinarslanA, et al.Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240(1):110–4.
